Chevy Chase Trust Holdings LLC Purchases 868 Shares of Agilent Technologies, Inc. $A

Chevy Chase Trust Holdings LLC boosted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 0.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 152,236 shares of the medical research company’s stock after acquiring an additional 868 shares during the period. Chevy Chase Trust Holdings LLC owned 0.05% of Agilent Technologies worth $17,965,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Stone House Investment Management LLC bought a new stake in Agilent Technologies during the 1st quarter worth approximately $30,000. Ransom Advisory Ltd bought a new stake in shares of Agilent Technologies during the first quarter valued at approximately $32,000. Central Pacific Bank Trust Division bought a new stake in shares of Agilent Technologies during the second quarter valued at approximately $33,000. Zions Bancorporation National Association UT bought a new stake in shares of Agilent Technologies during the first quarter valued at approximately $38,000. Finally, Costello Asset Management INC bought a new stake in shares of Agilent Technologies during the first quarter valued at approximately $47,000.

Agilent Technologies Trading Up 0.6%

A stock opened at $142.01 on Friday. The firm has a fifty day moving average price of $127.58 and a 200 day moving average price of $117.84. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. The firm has a market cap of $40.26 billion, a PE ratio of 33.34, a price-to-earnings-growth ratio of 4.63 and a beta of 1.26.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.37. The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. Agilent Technologies’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same period last year, the firm posted $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be paid a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies’s payout ratio is presently 23.24%.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on A shares. Wells Fargo & Company lifted their price objective on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a research report on Monday, September 15th. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Friday, October 3rd. TD Cowen lifted their price objective on shares of Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a research report on Tuesday, October 14th. Rothschild Redb raised shares of Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $149.62.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.